GlassScriptPhysician profile
Alissa B Fox
NPI 1780688697
$10,525.66
in general payments reported to CMS, 2019-2025
52 companies · $638 in 2025
The $638 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $1,943 · 2021: $1,818 · 2022: $1,937 · 2023: $1,299 · 2024: $1,189 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,178.21 | 2019-2025 | |
| Csl Behring | $1,009.52 | 2019-2025 | Hizentra, Haegarda, Andembry |
| Mayne Pharma Commercial LLC | $970.10 | 2019-2025 | |
| Galderma Laboratories, L.P. | $749.16 | 2019-2025 | Aklief |
| Glaxosmithkline, LLC. | $719.06 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $614.71 | 2019-2025 | Cabtreo, Arazlo |
| Amgen INC. | $577.95 | 2019-2025 | Otezla, Tezspire, Otezla |
| Novartis Pharmaceuticals Corporation | $541.98 | 2019-2024 | |
| Kaleo, INC. | $315.66 | 2019-2024 | Auvi-Q |
| Dermavant Sciences, INC. | $314.48 | 2023-2024 | Vtama |
| Covis Pharma Gmbh | $283.13 | 2021-2023 | |
| Vyne Pharmaceuticals INC. | $271.94 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $246.71 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $236.88 | 2022 | |
| Incyte Corporation | $193.33 | 2021-2023 | Opzelura |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alissa Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.